Buy Mankind Pharma for 15% short term Mankind Pharma
Take entry Near 2600Rs
Target will be 3055( almost 16% upside)
Invest more at 2477
Mankind look likes very bullish
Double bottom pattern perform on up trendline.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
46.60 INR
19.91 B INR
122.07 B INR
104.47 M
About Mankind Pharma Ltd.
Sector
Industry
CEO
Sheetal Arora
Website
Headquarters
New Delhi
Founded
1986
ISIN
INE634S01028
FIGI
BBG01G9WXGC8
Mankind Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations across acute and chronic therapeutic areas. It offers products under the brands of Nurokind, Telmikind, Manforce, Unwanted, Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Prega News, Dydroboon, Cefakind, Monticope, and Caldikind. The company was founded by Ramesh Chand Juneja in 1986 and is headquartered in New Delhi, India.
Related stocks
MANKIND Pharma Ready to blastNSE:MANKIND
Nice breakout, with volume surges.
Now trying to retest Support.
Good to keep on the radar
Always respect SL & position sizing
========================
Trade Secrets By Pratik
========================
Disclaimer
NOT SEBI REGISTERED
This is our personal view and this analysis
is onl
Mankind Pharma cmp 2578.30 by a Weekly Chart view since listedMankind Pharma cmp 2578.30 by a Weekly Chart view since listed
- Support Zone 2400 to 2500 Price Band
- Resistance Zone 2675 to 2785 Price Band
- Symmetrical Triangle Breakout well sustained
- Back to back Bullish Rounding Bottom with Resistance Zone neckline
- Most common Technical Indicators BB
MANKIND PHARMA – Descending Triangle Breakout________________________________________________________________________________📈 MANKIND PHARMA – Falling Trendline Breakout | Strong Reversal Candle | Volume Spike
🕒 Chart Type: Daily Chart
📆 Date: July 9, 2025
________________________________________________________________________________
📌 Pric
A clear Breakout in Mankind pharmaA clear breakout in mankind pharma, we can expect upto another 7 to 8 % rally from here. only for learning purpose and paper trade.
Synchronizing studiesThe stock has bottomed at important points as per various studies
Bullish Gartley
Wave 2c corrective ED
Price and Momentum indicator Divergence
Let's see how this develops as there is potential for a good upside move.
Mankind Pharma Ltd (MANKIND)Mankind Pharma’s revolves around developing, manufacturing, and marketing affordable, high-quality pharmaceutical and consumer healthcare products, with a focus on accessibility and scale.
Product Portfolio:
Offers a diverse range of generics, branded generics, and specialty drugs across therapeu
Mankind pharmacy at supportMankind pharma at support ,looking good for up move.It's quarterly result was also good. Target by brokerage firm is 2900, CMP-2379.
Please do your analysis before investing.
Mankind Pharma - Breakout out of Falling Wedge PatternMankind Pharma is one of the 4 largest Pharma from domestic market perspective. It has fallen 30% from peak price, but has recently given BO from fallen wedge pattern. This looks a great stock:
1. 4 brands are having top market share and growing
2. First Co. to make oral anti-obesity medicine
3. A
Mankind Pharma: Fundamental & Technical Analysis for TradersFinancial Performance Overview
Mankind Pharma, a leading player in the pharmaceutical sector, recently released its Q3 financial results for the period ending December 31, 2024. The company reported a 16.5% decline in net profit, falling to ₹384 crore from ₹460 crore in the same quarter last year.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
799MPL26
Mankind Pharma Limited 7.99% 16-APR-2026Yield to maturity
—
Maturity date
Apr 16, 2026
797MPL27
Mankind Pharma Limited 7.97% 16-NOV-2027Yield to maturity
—
Maturity date
Nov 16, 2027
799MPL26A
Mankind Pharma Limited 7.99% 16-OCT-2026Yield to maturity
—
Maturity date
Oct 16, 2026
See all MANKIND bonds
Frequently Asked Questions
The current price of MANKIND is 2,589.30 INR — it has increased by 0.58% in the past 24 hours. Watch Mankind Pharma Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Mankind Pharma Ltd. stocks are traded under the ticker MANKIND.
MANKIND stock has risen by 2.18% compared to the previous week, the month change is a 2.19% rise, over the last year Mankind Pharma Ltd. has showed a 5.00% increase.
We've gathered analysts' opinions on Mankind Pharma Ltd. future price: according to them, MANKIND price has a max estimate of 3,160.00 INR and a min estimate of 2,150.00 INR. Watch MANKIND chart and read a more detailed Mankind Pharma Ltd. stock forecast: see what analysts think of Mankind Pharma Ltd. and suggest that you do with its stocks.
MANKIND reached its all-time high on Dec 23, 2024 with the price of 3,054.80 INR, and its all-time low was 1,242.00 INR and was reached on May 22, 2023. View more price dynamics on MANKIND chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MANKIND stock is 1.94% volatile and has beta coefficient of 0.78. Track Mankind Pharma Ltd. stock price on the chart and check out the list of the most volatile stocks — is Mankind Pharma Ltd. there?
Today Mankind Pharma Ltd. has the market capitalization of 1.06 T, it has decreased by −3.36% over the last week.
Yes, you can track Mankind Pharma Ltd. financials in yearly and quarterly reports right on TradingView.
Mankind Pharma Ltd. is going to release the next earnings report on Nov 4, 2025. Keep track of upcoming events with our Earnings Calendar.
MANKIND earnings for the last quarter are 10.70 INR per share, whereas the estimation was 10.92 INR resulting in a −1.98% surprise. The estimated earnings for the next quarter are 13.70 INR per share. See more details about Mankind Pharma Ltd. earnings.
Mankind Pharma Ltd. revenue for the last quarter amounts to 35.70 B INR, despite the estimated figure of 36.04 B INR. In the next quarter, revenue is expected to reach 38.06 B INR.
MANKIND net income for the last quarter is 4.38 B INR, while the quarter before that showed 4.21 B INR of net income which accounts for 4.17% change. Track more Mankind Pharma Ltd. financial stats to get the full picture.
Mankind Pharma Ltd. dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 9, 2025, the company has 21.32 K employees. See our rating of the largest employees — is Mankind Pharma Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mankind Pharma Ltd. EBITDA is 32.10 B INR, and current EBITDA margin is 25.41%. See more stats in Mankind Pharma Ltd. financial statements.
Like other stocks, MANKIND shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mankind Pharma Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mankind Pharma Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mankind Pharma Ltd. stock shows the strong buy signal. See more of Mankind Pharma Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.